Genomic alterations and outcomes with fixed- duration ibrutinib plus venetoclax: results from the phase 3 GLOW Study in patients with previously untreated CLL
LEUKEMIA & LYMPHOMA(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
LEUKEMIA & LYMPHOMA(2023)